FDA Announced Herbal Supplement Kratom to Be an Opioid

FDA announced herbal supplement kratom which is a popular tropical tree acts as a stimulant to be an opioid on Tuesday.

US Food and Drug Administration Commissioner Dr. Scott Gottlieb broaden its warnings about Kratom, saying new research claims the herbal supplement has opioid properties and is associated with 44 deaths. He stated that there is no evidence to show that the unregulated botanical substance is safe or effective for any medical use.


The research reveals kratom acts in the brain just as other opioids do and FDA has found Kratom associated deaths cases.

Kratom which is also called as Mitragyna Speciosa is a plant in the coffee family native in Southeast Asia.  The kratom tree’s leaves are traditionally crushed and made into a tea and some people take it for treating chronic pain, for reducing opioid withdrawal cravings. There are 3 million to 5 million kratom users in the US, according to the American Kratom Association (AKA).

Kratom is widely available online. Federal agents have seized some kratom from retailers, but it was not immediately clear what the federal government plans to do about the many online outlets.

FDA unveiled that there are individuals suffering from opioid addiction and getting kratom-based treatment as they think it is safe and effective but they should follow health care provider.

“We recognize that some patients have tried available therapies, and still have unmet medical needs. We’re deeply committed to these patients, and to advancing new, safe and effective options for those suffering from these conditions,” the AKA said in a statement.

Share this post